University Hospital, Essen clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 116 studies whose lead sponsor is University Hospital, Essen. 33 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.
Keep track of what changes. Save the University Hospital, Essen studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions University Hospital, Essen leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 116. Browse all 116 →
- Prevalence of Obstructive Sleep Apnea in HHT and HHT-specific Challenges in OSA-therapy - a Retrospective Cohort StudyNot yet recruitingNCT07886632
- Optimization of Radiation Protection Through Genomic AnalysesRecruitingNCT06253338Not applicable
- Decompressive Craniectomy After Aneurysmal Subarachnoid Hemorrhage (DECIDE-SAH)Not yet recruitingNCT07872774
- Body Donation in HHTRecruitingNCT07826845Not applicable
- Mental Health and Suicidality in Glioblastoma Patients in GermanyRecruitingNCT07409584
- Proton vs. Photon Radiotherapy for Patients With WHO Grade 2-3 GliomaRecruitingNCT07750457Not applicable
- Theranostic PET for Target Validation and Tumor DetectionRecruitingNCT07664410
- Improving Adherence to Statin Therapy Through a Medication Management ApplicationRecruitingNCT05777655Not applicable
- Efficacy of Zoster Vaccination in Glioblastoma PatientsNot yet recruitingNCT07546669Phase 4
- Multimodal Analysis of Endomyocardial BiopsiesRecruitingNCT07359690
- Quality of Life and the Influence of Stress on the Postoperative Course of Patients After Device ImplantationRecruitingNCT07343466
- Hybrid Florbetaben PET/MRI for Imaging of Cardiac AmyloidosisRecruitingNCT07154381
- Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's DiseaseRecruitingNCT07154394
- Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)RecruitingNCT06784791Phase 2
- Essen Amyloidosis RegistryRecruitingNCT06887283
- Distrupt Stiffness TrialRecruitingNCT07130526Not applicable
- Quality of Life in Patients With Hemorrhagic TelangiectasiaEnrolling by invitationNCT06261333
- Impact of Stress on Cardiovascular Events in Patients with Peripheral Arterial DiseaseRecruitingNCT06887101
- Essen Coronary Artery Disease RegistryRecruitingNCT04196712
- MHealth Intervention to Reduce Perceived Stress in Patients with Ischemic Heart DiseaseRecruitingNCT05846334Not applicable
- Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic TelangiectasiaRecruitingNCT04469517
- HIV-HEART Aging StudyRecruitingNCT04330287
- Exercise in Patients With Advanced Non-small Cell Lung CancerNot yet recruitingNCT06374160Not applicable
- PROMISE PET Registry on PSMA-PET and Outcome in Prostate CancerRecruitingNCT06320223
- Lung_Cancer_adaptive - EthosRecruitingNCT06222190
- Vascular Effects Through Sirolimus vs. Paclitaxel DCB ImplantationRecruitingNCT05450042Not applicable
- The Biomimetic Stent and Vascular Functions StudyRecruitingNCT05447052Not applicable
- FAPI-PET for Tumor DetectionRecruitingNCT04571086
- Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney TransplantationRecruitingNCT06057545Phase 3
- Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK InhibitionRecruitingNCT04619316Phase 2
- SURgical Registry of ENDocarditis EuRopeNot yet recruitingNCT05563662
- Phase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC.RecruitingNCT04202809Phase 2
- AlloLife - Life After TransplantationNot yet recruitingNCT05087784Not applicable
- PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.CompletedNCT06247163
- Adaptive Radiotherapy in Patients With Gynecological TumorsCompletedNCT06230549Not applicable
- Adaptive Radiotherapy in Head and Neck Tumor PatientsCompletedNCT06216171Not applicable
- Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck TumorsCompletedNCT06214611Not applicable
- Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer PatientsCompletedNCT04205552Phase 2
- Andexanet Alfa: Non-interventional Study in Stroke Units in Germany (DE)CompletedNCT05127941
- Non-Invasive and Invasive Assessment of Heart Filling PressureCompletedNCT07512310
- Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate CancerTerminatedNCT06388369Phase 1/2
- Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract CancerCompletedNCT05052099Phase 1/2
- Optimization of Sepsis Therapy Based on Patient-specific Digital Precision DiagnosticsCompletedNCT04571801Not applicable
- Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic ShockCompletedNCT06006754
- Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines TrialCompletedNCT05636774Not applicable
- Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant MelanomaCompletedNCT02902029Phase 2
- Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients with HHTActive, not recruitingNCT03841422
- Tourniquet-Test in HHTActive, not recruitingNCT06266624Not applicable
- Registration of Idarucizumab for Patients with IntraCranial HemorrhageCompletedNCT04062097
- Dietary Inorganic Nitrate and the Enteral MicrobiomeCompletedNCT05122689Not applicable